Publication:
Outcome of ABO-Incompatible Living Donor Kidney Transplantation: A Single Center Observational Study from Nepal

creativeworkseries.issnISSN (Print) : 1993-2979 | ISSN (Online) : 1993-2987
dc.contributor.authorHamal, Saurav S
dc.contributor.authorNepali, Rabin
dc.contributor.authorPoudyal, Sujeet
dc.contributor.authorShah, Dibya S
dc.date.accessioned2026-02-11T10:29:46Z
dc.date.available2026-02-11T10:29:46Z
dc.date.issued2023
dc.descriptionSaurav S Hamal1, Rabin Nepali1, Sujeet Poudyal2, Dibya S Shah1 1Department of Nephrology and Transplant Medicine, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj Kathmandu, Nepal 2Department of Urology and Kidney Transplant Surgery, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj Kathmandu, Nepal
dc.description.abstractABSTRACT Introduction: Kidney transplantation is the most effective treatment for end-stage renal disease (ESRD) patients. However, the increasing number of ESRD patients and the limited availability of living and cadaveric donors has led to a growing waiting list for kidney transplantation. ABO-incompatible transplantation has emerged as an alternative for these patients in Nepal. Methods: This was an observational study of all the patients who underwent kidney transplantation from March 2017-Feb 2019. Data on demography of recipients and donor, blood group, human leukocyte antigen mismatch, induction agent, post-operative complications and creatinine clearance at discharge and one-year post-transplant were collected and analysed. Then we compared patient and kidney graft survival at one year between ABO incompatible and ABO compatible recipients. Results: During the study period, there were total of 124 kidney transplant recipients among them 12 were ABO incompatible and 112 were ABO compatible recipients. The study showed slightly lower patient and graft survival in ABO-incompatible recipients than ABO compatible recipients (83.3% vs 99.2%, p<0.001). However, death-censored graft survival were similar in both groups (100%,p<0.001). The graft function at one year measured by creatinine clearance was better in ABO-incompatible recipients than ABO-compatible recipients (67.1±11.75 vs 61.87±12.82, p<0.001). Postoperative complications were slightly higher, however, complications at one year were lower in ABO-incompatible recipients. Conclusion: The study showed that living donor ABO-incompatible kidney transplant recipients have a good outcome at one year but is associated with greater risks of patient and graft loss at early transplant period compared to ABO-compatible recipients. Keywords: ABO incompatible; graft survival; infection; kidney transplantation; patient survival; rejection
dc.identifier.urihttps://hdl.handle.net/20.500.14572/4694
dc.language.isoen_US
dc.publisherInstitute of Medicine
dc.subjectABO incompatible
dc.subjectgraft survival
dc.subjectinfection
dc.subjectkidney transplantation
dc.subjectpatient survival
dc.subjectrejection
dc.titleOutcome of ABO-Incompatible Living Donor Kidney Transplantation: A Single Center Observational Study from Nepal
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage49
oaire.citation.startPage45
relation.isJournalIssueOfPublicationfcf8e2e7-b9a0-4676-9f77-377d260949c7
relation.isJournalIssueOfPublication.latestForDiscoveryfcf8e2e7-b9a0-4676-9f77-377d260949c7
relation.isJournalOfPublicationa9ba45d9-ee33-4a6b-b1fc-6626b87eec6c

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
45-49.pdf
Size:
331.16 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections